Skip to content
10-Q

Quarterly Report

CITIUS ONCOLOGY, INC. CTOR

0001213900-26-057841

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · May 14, 2026 92.98M sh
Shares Diluted Q2 2026 · Mar 31, 2026 100.03M sh
Shares Diluted Q2 2026 · Mar 31, 2026 93.66M sh
Shares Diluted Q2 2026 · Mar 31, 2025 71.55M sh
Shares Diluted Q2 2026 · Mar 31, 2025 71.55M sh
Operating Cash Flow Q2 2026 · Mar 31, 2026 −$11.19M
Cash And Equivalents Q2 2026 · Mar 31, 2026 $2.63M
Cash And Equivalents Q2 2026 · Sep 30, 2025 $3.92M
Stockholders Equity Q2 2026 · Mar 31, 2026 $35.27M
Stockholders Equity Q2 2026 · Dec 31, 2025 $58.41M
Stockholders Equity Q2 2026 · Sep 30, 2025 $44.87M
Stockholders Equity Q2 2026 · Mar 31, 2025 $35.64M
Stockholders Equity Q2 2026 · Dec 31, 2024 $41.29M
Stockholders Equity Q2 2026 · Sep 30, 2024 $46.14M
Current Liabilities Q2 2026 · Mar 31, 2026 $58.81M
Current Liabilities Q2 2026 · Sep 30, 2025 $49.49M
Total Liabilities Q2 2026 · Mar 31, 2026 $65.43M
Total Liabilities Q2 2026 · Sep 30, 2025 $56.08M
Current Assets Q2 2026 · Mar 31, 2026 $29.42M
Current Assets Q2 2026 · Sep 30, 2025 $27.54M
Total Assets Q2 2026 · Mar 31, 2026 $100.7M
Total Assets Q2 2026 · Sep 30, 2025 $100.94M
Eps Diluted Q2 2026 · Mar 31, 2026 −$0.27
Eps Diluted Q2 2026 · Mar 31, 2026 −$0.34
Eps Diluted Q2 2026 · Mar 31, 2025 −$0.11
Eps Diluted Q2 2026 · Mar 31, 2025 −$0.20
Eps Basic Q2 2026 · Mar 31, 2026 −$0.27
Eps Basic Q2 2026 · Mar 31, 2026 −$0.34
Eps Basic Q2 2026 · Mar 31, 2025 −$0.11
Eps Basic Q2 2026 · Mar 31, 2025 −$0.20
Sga Expense Q2 2026 · Mar 31, 2026 $23.63M
Sga Expense Q2 2026 · Mar 31, 2026 $26.48M
Sga Expense Q2 2026 · Mar 31, 2025 $2.24M
Sga Expense Q2 2026 · Mar 31, 2025 $5.57M
Rd Expense Q2 2026 · Mar 31, 2026 $1.08M
Rd Expense Q2 2026 · Mar 31, 2026 $2.1M
Rd Expense Q2 2026 · Mar 31, 2025 $3.14M
Rd Expense Q2 2026 · Mar 31, 2025 $4.4M
Net Income Q2 2026 · Mar 31, 2026 −$26.61M
Net Income Q2 2026 · Mar 31, 2026 −$32.14M
Net Income Q2 2026 · Dec 31, 2025 −$5.53M
Net Income Q2 2026 · Mar 31, 2025 −$7.74M
Net Income Q2 2026 · Mar 31, 2025 −$14.39M
Net Income Q2 2026 · Dec 31, 2024 −$6.66M
Operating Income Q2 2026 · Mar 31, 2026 −$28.61M
Operating Income Q2 2026 · Mar 31, 2026 −$33.87M
Operating Income Q2 2026 · Mar 31, 2025 −$7.47M
Operating Income Q2 2026 · Mar 31, 2025 −$13.87M
Gross Profit Q2 2026 · Mar 31, 2026 $1.34M
Gross Profit Q2 2026 · Mar 31, 2026 $4.49M
Cost Of Revenue Q2 2026 · Mar 31, 2026 $328.88K
Cost Of Revenue Q2 2026 · Mar 31, 2026 $1.12M
Revenue Q2 2026 · Mar 31, 2026 $1.67M
Revenue Q2 2026 · Mar 31, 2026 $5.61M